Skip to main content

Table 6 Demographics, clinic, and process variables as predictors of Depression outcomes in SIF-CoCM AI/AN sites

From: Implementing collaborative care to reduce depression for rural native American/Alaska native people

Level

Response

Remission

N (%)

Odds Ratio

LowerCL

UpperCL

p-value

N (%)

Odds Ratio

LowerCL

UpperCL

p-value

Age

 age 18–34 (referent)

357 (42.1)

–

–

–

–

166 (19.6)

–

–

–

–

 age 35–54

328 (45.4)

0.9

0.7

1.2

0.600

153 (21.2)

0.9

0.7

1.2

0.560

 age 55–74

210 (54.0)

1.3

0.9

1.7

0.176

108 (27.8)

1.3

0.9

1.8

0.182

 age > =75

13 (81.3)

1.8

0.4

7.8

0.453

8 (50.0)

1.7

0.5

5.4

0.363

Race

 White (referent)

660 (44.8)

–

–

–

–

311 (21.1)

–

–

–

–

 AI/AN

182 (52.8)

1.2

0.7

1.8

0.523

87 (25.2)

0.9

0.6

1.4

0.654

 Other

71 (40.6)

0.9

0.6

1.3

0.485

38 (21.7)

1.4

0.9

2.2

0.177

Gender

 Male (referent)

307 (44.3)

–

–

–

–

135 (19.5)

–

–

–

–

 Female

600 (46.7)

1.1

0.8

1.4

0.605

299 (23.3)

1.3

1.0

1.8

0.036

Site

 Clinic C (referent)

294 (19.3)

–

–

–

–

638 (41.9)

–

–

–

–

 Clinic F

72 (34.8)

3.4

2.1

5.5

< 0.001

137 (66.2)

2.2

1.5

3.4

< 0.001

 Clinic G

70 (26.7)

0.9

0.6

1.5

0.779

138 (52.7)

1.0

0.6

1.7

0.922

Severity of Max PHQ

 continuous

–

0.8

0.8

0.8

< 0.001

–

0.8

0.8

0.9

< 0.001

Treatment Duration (months)

 continuous

–

1.1

1.1

1.2

< 0.001

–

1.1

1.0

1.1

0.009

Total Treatment Episodes

 1 episode (referent)

795 (47.5)

–

–

–

–

382 (22.8)

–

–

–

–

 two or more episodes

118 (37.0)

0.5

0.4

0.8

< 0.001

54 (16.9)

0.7

0.5

1.0

0.035

Total FU

 < =1 FU (referent)

95 (32.4)

–

–

–

–

40 (13.7)

–

–

–

–

 2–3 FU

208 (45.5)

2.4

1.7

3.5

< 0.001

87 (19.0)

1.8

1.1

2.8

0.011

 4–7 FU

268 (62.0)

4.9

3.3

7.3

< 0.001

149 (34.5)

4.4

2.8

7.0

< 0.001

  1. Initial predictors entered prior to variable selection: age, race, gender, treatment duration (months), number of episodes, number of follow-ups, first follow-up within 31 days, at least one psychiatric consultation note